Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard DeBiasio

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)|May 21, 2015
Fluorescent protein biosensors applied to microphysiological systemsNina Senutovitch, Lawrence Vernetti, Robert Boltz, et al.
Journal of Biomolecular Screening|August 12, 2005
Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor technologyRichik N Ghosh, Richard DeBiasio, Christine C Hudson, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 24, 2015
A human liver microphysiology platform for investigating physiology, drug safety, and disease modelsLawrence A Vernetti, Nina Senutovitch, Robert Boltz, et al.
Toxicology|December 28, 2020
A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®Kristin M Bircsak, Richard DeBiasio, Mark Miedel, et al.
BMC Biotechnology|May 1, 2026
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionJulio Aleman, Lawrence Vernetti, Mark E Schurdak, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionJulio Aleman, Lawrence Vernetti, Mark E Schurdak, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 15, 2017
Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systemsFelipe T Lee-Montiel, Subin M George, Albert H Gough, et al.
BMC Methods|February 11, 2026
Road map for primary hepatocyte qualification in human liver organ modelsMahboubeh Varmazyad, Dillon C Gavlock, Michael W Castiglione, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 26, 2014
In vitro platforms for evaluating liver toxicityShyam Sundhar Bale, Lawrence Vernetti, Nina Senutovitch, et al.
Stem Cell Research & Therapy|February 26, 2014
Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humansAbhinav Bhushan, Nina Senutovitch, Shyam S Bale, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Experimental Biology and Medicine (Maywood, N.J.)|May 21, 2015
Fluorescent protein biosensors applied to microphysiological systemsNina Senutovitch, Lawrence Vernetti, Robert Boltz, et al.
Journal of Biomolecular Screening|August 12, 2005
Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor technologyRichik N Ghosh, Richard DeBiasio, Christine C Hudson, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 24, 2015
A human liver microphysiology platform for investigating physiology, drug safety, and disease modelsLawrence A Vernetti, Nina Senutovitch, Robert Boltz, et al.
Toxicology|December 28, 2020
A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®Kristin M Bircsak, Richard DeBiasio, Mark Miedel, et al.
BMC Biotechnology|May 1, 2026
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionJulio Aleman, Lawrence Vernetti, Mark E Schurdak, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionJulio Aleman, Lawrence Vernetti, Mark E Schurdak, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 15, 2017
Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systemsFelipe T Lee-Montiel, Subin M George, Albert H Gough, et al.
BMC Methods|February 11, 2026
Road map for primary hepatocyte qualification in human liver organ modelsMahboubeh Varmazyad, Dillon C Gavlock, Michael W Castiglione, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 26, 2014
In vitro platforms for evaluating liver toxicityShyam Sundhar Bale, Lawrence Vernetti, Nina Senutovitch, et al.
Stem Cell Research & Therapy|February 26, 2014
Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humansAbhinav Bhushan, Nina Senutovitch, Shyam S Bale, et al.
Pageof 2